How to Get Alprostadil (Caverject/MUSE) in Mississippi

What Is Alprostadil and Why Is It Prescribed?

Alprostadil is a synthetic prostaglandin E1 that relaxes smooth muscle in the corpus cavernosum, dilates penile arteries, and produces an erection within 5 to 20 minutes of administration. Physicians prescribe it primarily for erectile dysfunction (ED) that has not responded adequately to oral phosphodiesterase-5 inhibitors such as sildenafil or tadalafil. It is also used after radical prostatectomy, when penile rehabilitation is part of the recovery plan.

The landmark randomized controlled trial by Linet and Ogrinc (N=683) published in the New England Journal of Medicine in 1996 reported that 94.8% of injections with intracavernosal alprostadil produced a response sufficient for intercourse, compared with 13.4% for placebo 1. That efficacy figure remains one of the highest reported for any ED treatment in a controlled setting.

Two delivery forms are approved by the FDA 2:

• Caverject (alprostadil for injection): Doses range from 1.25 mcg titrated up to a maximum of 60 mcg. Most men stabilize between 10 and 40 mcg per injection.
• MUSE (medicated urethral system for erection): A small suppository inserted 1 to 2 cm into the urethra. Available in 125, 250, 500, and 1000 mcg strengths.

The American Urological Association (AUA) 2018 guideline on erectile dysfunction lists intracavernosal alprostadil as a second-line treatment after oral PDE5 inhibitors fail or are contraindicated 3. Patients with documented contraindications to PDE5 inhibitors, including those taking nitrates for coronary artery disease, may receive alprostadil as a first-line option.

The Legal and Regulatory Framework in Mississippi

Mississippi permits licensed physicians, nurse practitioners, and physician assistants to prescribe alprostadil through both in-person encounters and telemedicine visits. The Mississippi State Department of Health and the Mississippi Board of Medical Licensure require that a prescriber hold an active Mississippi license or qualify under reciprocal recognition rules before issuing any controlled or legend drug prescription to a Mississippi patient 4.

Alprostadil is not a federally scheduled controlled substance. Under the Federal Analogue Act and the DEA's scheduling framework, prostaglandins are not listed in Schedules I through V 5. This means alprostadil does not trigger the special DEA-registration requirements that apply to testosterone or other Schedule III androgens, and a telehealth prescriber does not need an in-person evaluation mandated by the Ryan Haight Act to prescribe it.

Mississippi Medicaid (administered by the Mississippi Division of Medicaid) currently excludes alprostadil from its preferred drug list for erectile dysfunction. The program treats ED medications as a lifestyle category and does not reimburse Caverject or MUSE injections even when the underlying cause is diabetes or neurogenic injury 6. Patients relying on Mississippi Medicaid should plan to pay out of pocket or seek a manufacturer patient-assistance program.

Step-by-Step: How to Get Alprostadil in Mississippi

Step 1. Schedule a Qualifying Evaluation

A prescriber needs enough clinical information to confirm organic or mixed-etiology ED and to rule out contraindications. In-person urology appointments in Mississippi cities like Jackson, Gulfport, and Hattiesburg typically have 2 to 6 week wait times. A telehealth evaluation can often be completed within 24 to 72 hours.

During the visit, the clinician will review your medical history, current medications (especially nitrates, alpha-blockers, and anticoagulants), prior ED treatments, and cardiovascular risk factors. Men with sickle cell disease, multiple myeloma, leukemia, or anatomical penile deformities are generally excluded from alprostadil use per the FDA labeling 7.

Step 2. Complete Required Laboratory Testing

Most prescribers order baseline labs before starting alprostadil. The standard panel includes total and free testosterone, HbA1c, fasting glucose, a complete lipid panel, and a complete blood count. Some clinicians add a thyroid-stimulating hormone test, particularly when libido loss is part of the complaint. PSA is ordered when prostate cancer has not been recently excluded 8.

Endocrine Society guidelines state that testosterone deficiency should be identified and treated before or alongside ED therapy, since hypogonadism is a correctable contributor in 10 to 15% of ED cases 9. If your testosterone is below 300 ng/dL on two morning draws, a prescriber may recommend concurrent TRT 10.

Quest Diagnostics and LabCorp both maintain collection sites in Mississippi, including locations in Jackson (University Medical Center area), Biloxi, Meridian, and Tupelo. Most telehealth platforms provide a requisition form that directs patients to the nearest draw site.

Step 3. Receive Your Prescription

After the evaluation, the prescriber writes a prescription specifying the drug name (alprostadil), concentration, volume per dose, and number of doses. For Caverject, the prescription commonly reads "alprostadil 20 mcg intracavernosal injection, starting dose 2.5 mcg with titration in office or via telehealth follow-up." MUSE prescriptions specify suppository strength and quantity.

Because alprostadil is not a controlled substance, e-prescribing is straightforward in Mississippi. The prescription can be sent electronically to any retail pharmacy or mail-order pharmacy licensed in the state 11.

Step 4. Choose a Pharmacy

Mississippi patients have three main pharmacy options:

Retail chain pharmacies. Walgreens, CVS, and Walmart locations in Mississippi stock Caverject (10 mcg and 20 mcg kits) and MUSE suppositories, though availability varies by store. Calling ahead saves a wasted trip. The retail cash price for Caverject 20 mcg (6-injection kit) runs approximately $350, $500 without insurance. GoodRx coupons may reduce this to $150, $280 at certain Mississippi locations 12.

503A compounding pharmacies. A 503A pharmacy in Mississippi may prepare patient-specific alprostadil formulations, including concentration adjustments not available in commercial kits. Compounded alprostadil requires a valid prescription and must be dispensed pursuant to that specific prescription under Mississippi Board of Pharmacy rules that mirror USP 795 and USP 797 standards 13. Compounded intracavernosal papaverine/phentolamine/alprostadil (tri-mix) is a common alternative when monotherapy alprostadil proves insufficient, but tri-mix requires a separate evaluation and discussion 14.

Mail-order and telehealth-affiliated pharmacies. Licensed out-of-state mail-order pharmacies with a Mississippi permit can ship alprostadil to a Mississippi address. Packages typically arrive within 3, 7 business days. Cold-chain shipping (alprostadil for injection requires refrigeration at 2, 8°C / 36, 46°F) must be confirmed with the pharmacy before ordering 15.

Step 5. In-Office or Telehealth Dose Titration

The FDA label for Caverject mandates that the first injection be administered in a clinical setting to titrate the dose to an erection lasting no more than one hour 16. This requirement exists because the most serious adverse event, priapism (an erection lasting more than four hours), affects approximately 1.3% of patients during initial dose finding 1. Priapism is a urological emergency requiring aspiration or intracavernosal phenylephrine injection.

For MUSE, in-office titration is recommended but not always required. A test dose given in clinic allows the prescriber to check for hypotension, which occurs in roughly 3% of men using the urethral suppository 17.

Telehealth providers handling initial titration typically partner with local urgent care centers or urology offices in Mississippi that agree to administer the first dose under observation. Ask your telehealth provider at enrollment whether a Mississippi observation site is in their network.

Telehealth Prescribing of Alprostadil in Mississippi

Mississippi enacted its telehealth parity law (Senate Bill 2922) in 2018, and the Mississippi State Board of Medical Licensure subsequently clarified that telemedicine visits constitute a valid patient-physician relationship for most non-controlled prescriptions, including alprostadil 18. A telehealth provider must hold a valid Mississippi medical license or, for multi-state platforms, a license recognized by the Interstate Medical Licensure Compact (IMLC).

The HealthRX prescribing framework for alprostadil telehealth evaluations in Mississippi follows four checkpoints:

1. Identity verification. Government-issued ID confirming Mississippi residency.
2. Structured clinical questionnaire. Standardized ED history covering IIEF-5 score, cardiovascular review, medication reconciliation, and prior ED treatment history.
3. Lab review. Testosterone, HbA1c, and lipid results from within the past 12 months, or a new requisition issued at enrollment.
4. Synchronous video consultation. A live video call with a licensed Mississippi prescriber to review history, confirm examination data provided by the patient or a prior clinician, and document the plan.

After these checkpoints pass, the prescription is sent electronically to the patient's preferred pharmacy. Most patients complete this process in one to three days. Turnaround from prescription to delivery is typically five to ten business days when a mail-order pharmacy handles fulfillment.

National telehealth platforms currently licensed to prescribe in Mississippi and that treat ED include Hims, Roman, Blink Health, and HealthRX. Confirm current Mississippi licensure directly with each platform before enrolling, as licensure status changes 19.

Prior Authorization Requirements in Mississippi

Private insurers in Mississippi covering alprostadil typically require prior authorization. Documentation requirements vary by plan but usually include:

• A diagnosis code confirming organic or psychogenic ED (ICD-10 N52.x or F52.21)
• Documentation that at least one oral PDE5 inhibitor was tried and failed or is contraindicated
• A prescriber attestation letter explaining clinical necessity
• Lab results confirming the evaluation was completed

BlueCross BlueShield of Mississippi, Molina Healthcare Mississippi, and United Healthcare Mississippi plans each publish their own preferred drug lists. Patients should check their plan's formulary before assuming coverage 20. The prior authorization denial rate for alprostadil across major commercial insurers nationally runs approximately 30 to 45%, based on data compiled from CMS prior authorization transparency reports 21.

If prior authorization is denied, the prescriber can file an appeal citing the Linet NEJM study showing 94.8% response rate and the AUA guideline recommendation 1. A letter of medical necessity quoting AUA Guideline Statement 19 ("Physicians should offer intracavernosal vasoactive therapy as a second-line therapy in men who fail or cannot use first-line therapies") carries meaningful weight in the appeals process 22.

Safety Considerations Specific to Mississippi Patients

Mississippi has the highest prevalence of diagnosed diabetes in the United States, at 15.1% of adults as of 2022, per CDC surveillance data 23. Diabetic autonomic neuropathy and vasculopathy are among the most common organic causes of ED, and they increase sensitivity to alprostadil's vasodilatory effects. Prescribers in Mississippi are advised to start diabetic patients at the lower end of the dose range: 1.25 to 2.5 mcg for intracavernosal injection, rather than the 5 mcg starting dose sometimes used in non-diabetic patients 16.

Men with poorly controlled hypertension should have blood pressure below 160/100 mmHg before beginning alprostadil. The combination of alpha-adrenergic blockers (commonly prescribed for benign prostatic hyperplasia) with alprostadil may produce additive hypotension 24. Concurrent anticoagulation with warfarin or a direct oral anticoagulant increases bruising and hematoma risk at the injection site.

The FDA label carries a warning against use in men who have a penile implant already in place, and in those with known hypersensitivity to alprostadil 25. Injection-site fibrosis develops in roughly 3 to 5% of long-term users, typically appearing as a palpable nodule along the corpora. Patients should inspect the injection site at each use and report new firmness or angulation to their prescriber 26.

Transferring an Existing Prescription to Mississippi

Patients relocating to Mississippi from another state can transfer a non-controlled drug prescription directly. The receiving Mississippi pharmacy contacts the originating pharmacy to verify the prescription, remaining refills, and original prescriber details. Because alprostadil is not a controlled substance, no DEA transfer restrictions apply 27.

Patients using a telehealth platform from another state should verify that their current provider holds a Mississippi license before assuming continuity. If the platform lacks Mississippi licensure, the patient needs a new evaluation with a Mississippi-licensed prescriber. Telehealth platforms with a multi-state footprint often complete a new-state onboarding in two to five business days.

Mail-order pharmacies shipping from outside Mississippi must hold a valid Mississippi non-resident pharmacy permit issued by the Mississippi Board of Pharmacy. Patients can verify a pharmacy's Mississippi permit status at the Mississippi Board of Pharmacy's online license lookup tool 28.

Cost and Patient Assistance Programs

Pfizer (the manufacturer of Caverject) offers an Rx Pathways patient assistance program for patients below 400% of the federal poverty level. Applications are submitted at PfizerRxPathways.com with proof of income and a prescriber enrollment form 29.

MUSE (manufactured by Meda Pharmaceuticals, now Mylan/Viatris) does not have a standalone patient assistance program as of this writing, but GoodRx and RxSaver discount cards reduce retail cost at Mississippi pharmacies by 30 to 55% at participating chains 30.

Generic alprostadil for injection is available and FDA-approved. Compounded alprostadil from a 503A pharmacy may cost $60, $120 for a 10-dose vial, compared with $350, $500 for branded Caverject. The prescriber must specify "brand medically necessary" if branded Caverject is required; otherwise the pharmacy may substitute a generic or compounded version depending on what the formulary or patient-assistance arrangement allows 31.

What to Expect After Starting Treatment

Most men experience a functional erection within 5 to 20 minutes of intracavernosal alprostadil injection. Duration depends on dose and ranges from 30 to 90 minutes at therapeutic doses. Pain at the injection site occurs in approximately 10 to 30% of men and is the most common reason for discontinuing intracavernosal therapy 1. The penile pain is usually mild to moderate and decreases with continued use.

MUSE produces erections within 10 minutes in responsive patients, though the erection is generally less rigid than with intracavernosal injection. A medicated urethral applicator (MURA) is typically provided in the kit and instructions for use are included in the FDA-approved labeling 32.

Men using alprostadil should avoid using more than one injection per 24-hour period and should not exceed three injections per week per FDA label guidance. Exceeding these limits increases fibrosis risk without proportional efficacy gains 16.

Follow-up visits are scheduled at 30 days after starting treatment to review dose adequacy, injection technique, and any adverse events. Mississippi telehealth providers typically conduct this follow-up via video or asynchronous messaging within their platform.